Related Experiment Video
Updated: Sep 10, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Biological functions of FASN in tumor lipid metabolism and research advances in its covalent modifications
Wei Duan1, Na Jiang2, Yan Wang2
1School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Abstract:
De novo lipogenesis (DNL) operates as a core metabolic pathway in cellular lipid homeostasis, yet its central effector enzyme fatty acid synthase (FASN) undergoes aberrant overexpression and hyperactivation in tumors and metabolic disorders. Herein, we systematically outline the versatile functions of FASN in tumor lipogenic metabolism and summarize recent advances in its covalent regulatory modifications. We highlight nucleic acids methylation modifications, acetylation, ubiquitination, glycosylation, ubiquitin-like modification, palmitoylation and phosphorylation modifications as an integrated network that tune FASN stability, catalytic activity, and subcellular localization. These modifications exhibit extensive crosstalk and disease-specific heterogeneity, offering potential molecular targets for therapeutic intervention in cancer and metabolic diseases.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
